Ona Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Barcelona
Business model:B2B

Ona Therapeutics develops a new drug aimed at blocking CD36 and inhibiting metastasis-forming cells. This therapeutic approach could prevent metastasis formation and remove existing, potentially any type of cancer.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 35.65M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Ona Therapeutics

Name Criteria
Spain Bigfinite
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Trialbee
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
57%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Gesynta Pharma
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
53%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top